3268 How CellVoyant is Predicting Cell Outcomes Before They Happen with AI
In today's episode, I had the opportunity to speak with Rafael Carazo Salas, a scientist, entrepreneur, and the CEO and founder of CellVoyant. This is a conversation that goes beyond the hype around AI to reveal how machine learning is reshaping the future of healthcare in ways that are both profound and immediate. CellVoyant, a spinout from the University of Bristol, is using AI and advanced imaging technology to solve one of the most persistent challenges in biotech: the cost, time, and complexity involved in developing cell therapies. Rafael explained how his team is applying real-time…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.